Share
Journal Information
Issue
Vol. 27. Issue 1.(January - February 2022)
Editorial
Building a culture of scientific integrity among the academic and research communities of Latin America
Alexis Jose-Abrego, Arturo Panduro
Ann Hepatol. 2022;27:100655
Open access
Opinions
Glycemic control, the unconsidered outcome in the treatment of nonalcoholic fatty liver disease
Diego García-Compeán, Emanuela Orsi, Tsutomu Nishida, Ramesh Kumar
Ann Hepatol. 2022;27:100648
Open access
Concise reviews
Management of hepatocellular carcinoma recurrence after liver transplantation
Parul D. Agarwal, Michael R. Lucey
Ann Hepatol. 2022;27:100654
Open access
Management of COVID-19 patients with chronic liver diseases and liver transplants
Xinyu Hu, Longyan Sun, Zhaoyang Guo, Chao Wu, Xin Yu, Jie Li
Ann Hepatol. 2022;27:100653
Open access
Milestones
From Child-Pugh to MELD score and beyond: Taking a walk down memory lane
Andres Ruf, Melisa Dirchwolf, Richard B. Freeman
Ann Hepatol. 2022;27:100535
Open access
Original articles
One-step diagnosis strategy together with multidisciplinary telematics referral perform an effective approach for identifying and treating patients with active Hepatitis C infection
Miriam Torrecillas, Neus Gómez-Muñoz, María Dolores Ocete, Purificación Rubio Cuevas, Moisés Diago Madrid, Enrique Ortega González, Concepción Gimeno Cardona, Miguel García-Deltoro
Ann Hepatol. 2022;27:100542
Open access
A novel non-invasive score for the prediction of advanced fibrosis in patients with chronic hepatitis B
Sannur Okdemir, Erol Cakmak
Ann Hepatol. 2022;27:100544
Open access
EncephalApp Stroop Test validation for the screening of minimal hepatic encephalopathy in Brazil
Marlone Cunha-Silva, Fernando L. Ponte Neto, Priscila S. de Araújo, Lucas V. Pazinato, Raquel D. Greca, Tirzah M.L. Secundo, Marcello R. Imbrizi, Leonardo T. Monici, ... Daniel F. Mazo
Ann Hepatol. 2022;27:100543
Open access
The influence of hepatitis C virus eradication on hepatocarcinogenesis in patients with hemophilia
Yosuke Inukai, Norihiro Imai, Kenta Yamamoto, Takanori Ito, Yoji Ishizu, Takashi Honda, Shuichi Okamoto, Takeshi Kanematsu, ... Mitsuhiro Fujishiro
Ann Hepatol. 2022;27:100545
Open access
Cohort study: Apparent redundancy of fibrosis assessment in young persons with HCV; development of realistic approaches to break the paradigm
Brennan Paul Noel, Cartlidge Peter, Robinson Emma, Amarthingalam Asthika, Dillon John Francis
Ann Hepatol. 2022;27:100550
Open access
Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C
Pegah Golabi, James M. Paik, Katherine Eberly, Leyla de Avila, Saleh A. Alqahtani, Zobair M. Younossi
Ann Hepatol. 2022;27:100556
Open access
Efficacy comparison of optimal treatments for hepatocellular carcinoma patients with portal vein tumor thrombus
Yu Zhang, Jun-Li Wu, Le-Qun Li
Ann Hepatol. 2022;27:100552
Open access
Circ_0078710 promotes the development of liver cancer by upregulating TXNDC5 via miR-431-5p
Huajun Lu, Lili Gao, Jixiang Lv
Ann Hepatol. 2022;27:100551
Open access
Clinical features and treatment outcomes of primary biliary cholangitis in a highly admixed population
Guilherme Grossi Lopes Cançado, Michelle Harriz Braga, Maria Lúcia Gomes Ferraz, Cristiane Alves Villela-Nogueira, Debora Raquel Benedita Terrabuio, Eduardo Luiz Rachid Cançado, Mateus Jorge Nardelli, Luciana Costa Faria, ... Members of the Brazilian Cholestasis Study Group Consortium
Ann Hepatol. 2022;27:100546
Open access
Aging impairs fibrosis-4 index after sustained virologic response by direct-acting antivirals in chronic hepatitis C infection
Tomoaki Nakajima, Yoshiyasu Karino, Shuhei Hige, Hirokazu Suii, Ryoji Tatsumi, Masakatsu Yamaguchi, Tomohiro Arakawa, Yasuaki Kuwata, Joji Toyota
Ann Hepatol. 2022;27:100566
Open access
Brief report
LDL particle size and antioxidant HDL function improve after sustained virological response in patients with chronic HCV
Jose Ignacio Vargas, Katherine Rivera, Marco Arrese, Carlos Benitez, Francisco Barrera, Monrroy Hugo, Juan Pablo Arab, Karla Pino, ... Alejandro Soza
Ann Hepatol. 2022;27:100555
Open access
Letters to the editor
A case of unusual mild clinical presentation of COVID-19 vaccine-induced immune thrombotic thrombocytopenia with splanchnic vein thrombosis
Merel M.H. van Dijk, Hidde D. Veldman, Frits Aarts, Dennis G. Barten, Joop P van den Bergh, Arne W.J.H. Dielis
Ann Hepatol. 2022;27:100590
Open access
Publish in
Annals of Hepatology
Special content about COVID-19
- Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study
- Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cells
- P-2 NASH IS IMPROVED THROUGH MODIFICATIONS IN H3K9 METHYLATION BY PIRFENIDONE ACTING AS JMJD2B DEMETHYLASE ANTAGONIST.
- O-2 EVALUATION OF RISK FACTORS AND PROGNOSIS OF HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION
Affiliated societies
